
A clinical trial led by a UVA Health cancer expert has identified a better way to treat brain tumors known as grade 2 gliomas.
A clinical trial led by a UVA Health cancer expert has identified a better way to treat brain tumors known as grade 2 gliomas.
An anonymous gift will help us find better ways to treat "neglected" blood cancers and will also make it possible for more people to access our clinical trials.
Turns out that two forms of rhabdomyosarcoma are caused by the same gene that causes glioblastoma, the deadliest brain tumor.
Our Dr. Mark Russell, a skin cancer expert, has some helpful summertime advice.
Our David Schiff, MD, has helped lead the development of important new guidelines that will improve care for brain metastases -- cancers that spread to the brain.
The National Cancer Institute has designated UVA Cancer one of only 52 Comprehensive Cancer Centers in the country. It's an honor reserved for the most outstanding cancer programs in the nation.